Journals / Bağcılar Tıp Bülteni / 2020 / Cilt: 5 - Sayı: 4

C-reactive Protein to Albumin Ratio as aPrognostic Predictor in Larynx Cancer

Larinks Kanserinde Prognostik Bir Belirteç Olarak C-reaktif Protein Albümin Oranı

Pages
179–184
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The 5ySrates of patients with a high CAR were worse than those in the low group(79.2% vs 73.2% p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: During the past decade, several inflammation-basedprognostic systems have been reported in the field of clinical oncology.Recently, C-reactive protein and albumin ratio (CAR) have showedtheir impact on a large variety of tumor types.
📊
Key Findings & Data:The aim of this study isto evaluate the impact CAR on prognosis and 5-year survival (5yS) inpatients operated for larynx cancer.
💡
Conclusion & Impact:The 5ySrates of patients with a high CAR were worse than those in the low group(79.2% vs 73.2% p
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: During the past decade, several inflammation-basedprognostic systems have been reported in the field of clinical oncology.Recently, C-reactive protein and albumin ratio (CAR) have showedtheir impact on a large variety of tumor types. The aim of this study isto evaluate the impact CAR on prognosis and 5-year survival (5yS) inpatients operated for larynx cancer. Method: One hundred eighteen patients operated in our center between2010 and 2015 were eligible for retrospective analysis. We evaluated theimpact of the CAR and neutrophil to lymphocyte ratio (NLR) on the 5yS.Univariate and multivariate Cox regression analyses were performed todetermine the associations of CAR.Results: The optimal cut-off level of CAR was at 0.993. A low and highCAR was assigned to 40.7% and 59.3% of patients, respectively. The 5ySrates of patients with a high CAR were worse than those in the low group(79.2% vs 73.2% p

Özet

Amaç: Geçtiğimiz on yıl boyunca, klinik onkoloji alanında enflamasyontemelli birkaç prognostik sistem bildirilmiştir. Son zamanlarda, C-reaktifprotein ve albümin oranı (CAO), çok çeşitli tümör tipleri üzerindeprognostik belirteç olarak kendini göstermiştir. Bu çalışmanın amacı,larinks kanseri nedeniyle opere edilen hastalarda CAO’nun prognoz ve 5yıllık sağkalım üzerine etkisini değerlendirmektir. Yöntem: 2010-2015 yılları arasında merkezimizde ameliyat edilen 118hasta retrospektif analiz için uygun bulunmuştur. CAO ve nötrofil lenfositoranın (NLO) 5 yıllık sağkalım üzerindeki etkisi değerlendirildi. CAO ilesağkalım ve prognoz arasındaki ilişkileri belirlemek için tek değişkenli veçok değişkenli Cox regresyon analizi yapıldı. Bulgular: CAO’nun optimal cut-off seviyesi 0,993 olarak hesaplandı.Hastaların sırasıyla %40,7 ve %59,3’ünde düşük ve yüksek CAO saptandı.Yüksek CAO’lu hastaların 5 yıllık sağkalım oranları düşük gruptakileregöre daha kötü idi (%79,2’ye karşı %73,2, p

🔖

Cite This Article

ÖĞREDEN, Ş., OKTAY, M. F., TANSUKER, H. D., CENGİZ, A. B., GÜMÜŞLÜ, B. C., KAYABAŞI, S. (2022). C-reactive Protein to Albumin Ratio as aPrognostic Predictor in Larynx Cancer. Bağcılar Tıp Bülteni, Cilt: 5 - Sayı: 4, 179–184. https://ajindex.com/articles/458971

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57(1):43-66
  2. Megwalu UC, Sikora AG. Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg 2014;140(9):855-860
  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69(1):7-34
  4. Zuniga SA, Lango MN. Effect of rural and urban geography on larynx cancer incidence and survival. Laryngoscope 2018;128(8):1874- 1880
  5. Cayir S, Hizli O, Kayabasi S. Is C-reactive protein to albumin ratio an indicator of poor prognosis in Bell’s palsy? Eur Arch Otorhinolaryngol 2020;277(1):115-119
  6. McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 2013;39(5):534-540
  7. Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, et al. Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection. Clin Infect Dis 2005;40(12):1855-1857
  8. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004;17(6):432-437
  9. Nakayama M, Tabuchi K, Hara A. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer. Head Neck 2015;37(12):1745-1749
  10. Hanai N, Sawabe M, Kimura T, Suzuki H, Ozawa T, Hirakawa H, et al. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer. Oncotarget 2018;9(97):37008- 37016. 11. van der Voet JC, Keus RB, Hart AA, Hilgers FJ, Bartelink H. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys 1998;42(2):247-255
  11. Adeel M, Faisal M, Rashid A, Rasheed S, Hussain R, Malik KI, et al. Outcomes of definitive radiotherapy for early laryngeal cancer in terms of survival and patterns of failure. J Laryngol Otol 2019;133(12):1087-1091
  12. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357(9255):539-545
  13. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454(7203):436-444
  14. Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, et al. The C-reactive protein/albumin ratio, a novel inflammation- based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol 2015;22(3):803-810
  15. Brescia G, Mario